查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1702937

2025年生物防禦全球市場報告

Biodefense Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年生物防禦市場規模將強勁成長。到 2029 年，這一數字將成長至 287.5 億美元，複合年成長率為 9.1%。預測期內的成長可歸因於新感染疾病的不斷出現、生物技術的進一步飛躍、支持全球生物防禦工作的國際合作和資金籌措機制的加強、生物防禦基礎設施的建設和升級、公眾對生物防禦的認知和教育的提高、支持創新生物防禦技術的政策和法律規範的不斷發展，以及私營部門對生物防禦研究和開發的投資增加。預測期內的關鍵趨勢包括在預測建模、威脅檢測和新生物防禦工具開發中使用人工智慧和機器學習；整合遠端醫療和遠端監控技術，以便儘早發現和管理生物威脅；專注於下一代疫苗和治療方法的開發；人工智慧主導的藥物發現和開發過程；並改進了基因組監測和資料分析。

由於新興感染疾病的持續威脅，生物防禦市場預計將會成長。這些疾病由細菌、病毒、寄生蟲和真菌等多種微生物引起，凸顯了生物防禦領域在病原體控制、快速反應策略、全球協調和準備方面持續面臨的挑戰。生物防禦對於控制感染疾病和減少對公共衛生的影響至關重要，因為它可以提高防範能力、早期發現和快速應對生物威脅的能力。例如，世界衛生組織（WHO）在2023年11月估計，2022年全球結核病病例數約1,060萬，影響全球數百萬人。這些反覆出現的威脅正在推動生物防禦市場的成長。

生物防禦領域的主要企業正在積極開發鼻內新冠疫苗等創新解決方案，以加強世界對生物危害的防範。經鼻吸入型疫苗具有易於給藥、潛在的黏膜免疫、減少對針頭的依賴、增加可用性以及增強免疫反應的潛力等優點。例如，印度生物技術國際有限公司於 2023 年 1 月推出了經鼻吸入型疫苗iNCOVACC。該疫苗採用含有融合前穩定刺突蛋白的重組複製缺陷型腺病毒載體開發，並已在 I、II 和 III 期試驗中成功通過測試。它透過滴鼻劑給藥，兩次劑量間隔四周，每個鼻孔滴四滴。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球生物防禦PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球生物防禦市場：成長率分析
  • 全球生物防禦市場表現：規模與成長，2019-2024
  • 全球生物防禦市場預測：2024-2029年及2034年規模與成長
  • 全球生物防禦總目標市場（TAM）

第6章市場區隔

  • 全球生物防禦市場：依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 炭疽菌
  • 天花
  • 肉毒桿菌中毒
  • 輻射或核
  • 其他類型
  • 全球生物防禦市場（以生物威脅偵測設備）現況及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 採樣器
  • 檢測器或觸發裝置
  • 識別符
  • 測定
  • 其他生物武器偵測裝置
  • 全球生物防禦市場：依應用、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 門診治療中心
  • 其他用途
  • 全球生物防禦市場炭疽菌細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 炭疽菌疫苗
  • 炭疽菌治療
  • 全球生物防禦市場天花細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 天花疫苗
  • 天花抗病毒藥物
  • 全球生物防禦市場肉毒桿菌細分市場（按類型、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 肉毒桿菌抗毒素
  • 肉毒桿菌疫苗
  • 肉毒桿菌抑制劑
  • 全球生物防禦市場依放射性或核型細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 防輻射藥物
  • 醫療措施
  • 全球生物防禦市場及其他細分市場，依類型、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 離胺酸
  • 瘟疫
  • 土拉菌病
  • 病毒性出血熱
  • 其他生物毒素或生物威脅劑

第7章 區域和國家分析

  • 全球生物防禦市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球生物防禦市場：依國家、表現及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 生物防禦市場：競爭格局
  • 生物防禦市場：公司簡介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • AstraZeneca Plc
  • GSK plc
  • Gilead Sciences Inc
  • Biogen Inc
  • Novavax Inc
  • Ichor Medical Systems
  • Emergent BioSolutions Inc.
  • Alnylam Pharmaceuticals Inc.
  • Dynavax Technologies
  • Bavarian Nordic
  • Siga Technologies Inc.
  • Elusys Therapeutics Inc.
  • Ology Bioservices
  • Altimmune Inc.
  • Hytest Limited

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年生物防禦市場：提供新機會的國家
  • 2029年生物防禦市場：細分領域帶來新機會
  • 2029年生物防禦市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r29593

Biodefense encompasses strategies and measures aimed at safeguarding against biological threats, including intentional releases of pathogens or biotoxins. These efforts involve developing detection systems, vaccines, treatments, and emergency response plans to minimize the impact of biological attacks on public health and safety. Additionally, biodefense includes research and policies to prevent the misuse of biological agents.

The primary types of biodefense include anthrax, smallpox, botulism, radiation or nuclear threats, and others. Anthrax is a severe infectious disease caused by Bacillus anthracis, affecting humans and animals. It can be contracted through skin contact, inhalation, or ingestion of spores. Various biothreat detection devices, such as samplers, detectors, identifiers, assays, and more, are utilized in settings such as hospitals, clinics, ambulatory care centers, and beyond.

The biodefense research report is one of a series of new reports from The Business Research Company that provides biodefense market statistics, including the biodefense industry's global market size, regional shares, competitors with a biodefense market share, detailed biodefense market segments, market trends and opportunities, and any further data you may need to thrive in the biodefense industry. This biodefense market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biodefense market size has grown strongly in recent years. It will grow from $18.55 billion in 2024 to $20.29 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increased government investment in biodefense programs and initiatives, strengthening of regulatory frameworks to fast-track the approval of biodefense products and technologies, enhanced collaboration between government agencies, private sector companies, and academic institutions, rising geopolitical tensions and concerns over bioterrorism.

The biodefense market size is expected to see strong growth in the next few years. It will grow to $28.75 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to the continued emergence of new infectious diseases, further breakthroughs in biotechnology, strengthening of international collaboration and funding mechanisms to support global biodefense efforts building and upgrading biodefense infrastructure, increasing public awareness and education on biodefense, continued evolution of policies and regulatory frameworks to support innovative biodefense technologies, growing investment from the private sector in biodefense research and development. Major trends in the forecast period include leveraging AI and machine learning for predictive modeling, threat detection, and the development of new biodefense tools, integration of telehealth and remote monitoring technologies for early detection and management of biological threats, focus on the development of next-generation vaccines and therapeutics, AI-driven drug discovery and development processes, improved genomic surveillance and data analytics.

The biodefense market is anticipated to experience growth due to the persistent threat of emerging infectious diseases. These diseases, caused by various microorganisms such as bacteria, viruses, parasites, or fungi, highlight the ongoing challenges in pathogen control, rapid response strategies, global coordination, and readiness within the biodefense sector. Biodefense is crucial for managing infectious diseases by improving preparedness, early detection, and swift response to biological threats, thus mitigating their impact on public health. For example, in November 2023, the World Health Organization (WHO) estimated a global tuberculosis (TB) case count of around 10.6 million in 2022, affecting millions of individuals worldwide. This recurring threat underscores the driving force behind the growth of the biodefense market.

Leading companies in the biodefense sector are actively developing innovative solutions, such as nasal COVID-19 vaccines, to bolster global readiness against biological hazards. Nasal vaccines offer advantages such as easier administration, potential for mucosal immunity, reduced reliance on needles, increased accessibility, and potentially enhanced immune responses. For instance, Bharat Biotech International Limited launched the iNCOVACC Nasal COVID-19 vaccine in January 2023. This vaccine, developed using a recombinant replication-deficient adenovirus vector with a pre-fusion stabilized spike protein, underwent successful phase I, II, and III trials. Administered via nasal drops, it involves a 2-dose series given 4 weeks apart, with 4 drops into each nostril.

In September 2022, Emergent BioSolutions Inc. acquired worldwide rights to the TEMBEXA (brincidofovir) smallpox oral antiviral drug from Chimerix for $238 million. This acquisition underscores Emergent BioSolutions' commitment to advancing public health initiatives and addressing global health threats, particularly against smallpox outbreaks. Chimerix Inc., a biotechnology research company, is known for providing biodefense solutions.

Major companies operating in the biodefense market are Pfizer Inc., Johnson & Johnson, Merck & Co., Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GSK plc, Gilead Sciences Inc, Biogen Inc, Novavax Inc, Ichor Medical Systems, Emergent BioSolutions Inc., Alnylam Pharmaceuticals Inc., Dynavax Technologies, Bavarian Nordic, Siga Technologies Inc., Elusys Therapeutics Inc., Ology Bioservices, Altimmune Inc., Hytest Limited, XOMA Corporation, Cleveland BioLabs Inc., Inovio Pharmaceuticals Inc, Dynport Vaccine Company, ViralClear Pharmaceuticals

North America was the largest region in the biodefense market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biodefense market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biodefense market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biodefense market consists of revenues earned by entities by providing services such as threat assessment, surveillance, training, consultation, strategy development, emergency planning, and facility management. The market value includes the value of related goods sold by the service provider or included within the service offering. The biodefense market also includes sales of detection equipment, personal protective gear, vaccines and pharmaceuticals, biological agent identification kits, biocontainment equipment, emergency response kits, biosecurity systems, and communication systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biodefense Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biodefense market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biodefense ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biodefense market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Anthrax; Smallpox; Botulism; Radiation Or Nuclear; Other Types
  • 2) By Biothreat Detection Device: Samplers; Detectors Or Triggering Devices; Identifiers; Assays; Other Biothreat Detection Devices
  • 3) By Application: Hospitals And Clinics; Ambulatory Care Centers; Other Applications
  • Subsegments:
  • 1) By Anthrax: Bacillus Anthracis Vaccine; Anthrax Therapeutics
  • 2) By Smallpox: Smallpox Vaccine; Antiviral Drugs For Smallpox
  • 3) By Botulism: Botulism Antitoxin; Botulism Vaccine; Botulinum Neurotoxin Inhibitors
  • 4) By Radiation Or Nuclear: Radiation Protection Drugs; Medical Countermeasures
  • 5) By Other Types: Ricin; Plague; Tularemia; Viral Hemorrhagic Fevers; Other Biotoxins Or Biothreat Agents
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co.; Sanofi SA; Bristol-Myers Squibb Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biodefense Market Characteristics

3. Biodefense Market Trends And Strategies

4. Biodefense Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Biodefense Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Biodefense PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Biodefense Market Growth Rate Analysis
  • 5.4. Global Biodefense Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Biodefense Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Biodefense Total Addressable Market (TAM)

6. Biodefense Market Segmentation

  • 6.1. Global Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Anthrax
  • Smallpox
  • Botulism
  • Radiation Or Nuclear
  • Other Types
  • 6.2. Global Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Samplers
  • Detectors Or Triggering Devices
  • Identifiers
  • Assays
  • Other Biothreat Detection Devices
  • 6.3. Global Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Care Centres
  • Other Applications
  • 6.4. Global Biodefense Market, Sub-Segmentation Of Anthrax, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacillus Anthracis Vaccine
  • Anthrax Therapeutics
  • 6.5. Global Biodefense Market, Sub-Segmentation Of Smallpox, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Smallpox Vaccine
  • Antiviral Drugs For Smallpox
  • 6.6. Global Biodefense Market, Sub-Segmentation Of Botulism, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Botulism Antitoxin
  • Botulism Vaccine
  • Botulinum Neurotoxin Inhibitors
  • 6.7. Global Biodefense Market, Sub-Segmentation Of Radiation Or Nuclear, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radiation Protection Drugs
  • Medical Countermeasures
  • 6.8. Global Biodefense Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ricin
  • Plague
  • Tularemia
  • Viral Hemorrhagic Fevers
  • Other Biotoxins Or Biothreat Agents

7. Biodefense Market Regional And Country Analysis

  • 7.1. Global Biodefense Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Biodefense Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biodefense Market

  • 8.1. Asia-Pacific Biodefense Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biodefense Market

  • 9.1. China Biodefense Market Overview
  • 9.2. China Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biodefense Market

  • 10.1. India Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biodefense Market

  • 11.1. Japan Biodefense Market Overview
  • 11.2. Japan Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biodefense Market

  • 12.1. Australia Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biodefense Market

  • 13.1. Indonesia Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biodefense Market

  • 14.1. South Korea Biodefense Market Overview
  • 14.2. South Korea Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biodefense Market

  • 15.1. Western Europe Biodefense Market Overview
  • 15.2. Western Europe Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biodefense Market

  • 16.1. UK Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biodefense Market

  • 17.1. Germany Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biodefense Market

  • 18.1. France Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biodefense Market

  • 19.1. Italy Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biodefense Market

  • 20.1. Spain Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biodefense Market

  • 21.1. Eastern Europe Biodefense Market Overview
  • 21.2. Eastern Europe Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biodefense Market

  • 22.1. Russia Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biodefense Market

  • 23.1. North America Biodefense Market Overview
  • 23.2. North America Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biodefense Market

  • 24.1. USA Biodefense Market Overview
  • 24.2. USA Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biodefense Market

  • 25.1. Canada Biodefense Market Overview
  • 25.2. Canada Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biodefense Market

  • 26.1. South America Biodefense Market Overview
  • 26.2. South America Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biodefense Market

  • 27.1. Brazil Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biodefense Market

  • 28.1. Middle East Biodefense Market Overview
  • 28.2. Middle East Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biodefense Market

  • 29.1. Africa Biodefense Market Overview
  • 29.2. Africa Biodefense Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Biodefense Market, Segmentation By Biothreat Detection Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Biodefense Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biodefense Market Competitive Landscape And Company Profiles

  • 30.1. Biodefense Market Competitive Landscape
  • 30.2. Biodefense Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

31. Biodefense Market Other Major And Innovative Companies

  • 31.1. AstraZeneca Plc
  • 31.2. GSK plc
  • 31.3. Gilead Sciences Inc
  • 31.4. Biogen Inc
  • 31.5. Novavax Inc
  • 31.6. Ichor Medical Systems
  • 31.7. Emergent BioSolutions Inc.
  • 31.8. Alnylam Pharmaceuticals Inc.
  • 31.9. Dynavax Technologies
  • 31.10. Bavarian Nordic
  • 31.11. Siga Technologies Inc.
  • 31.12. Elusys Therapeutics Inc.
  • 31.13. Ology Bioservices
  • 31.14. Altimmune Inc.
  • 31.15. Hytest Limited

32. Global Biodefense Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biodefense Market

34. Recent Developments In The Biodefense Market

35. Biodefense Market High Potential Countries, Segments and Strategies

  • 35.1 Biodefense Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Biodefense Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Biodefense Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer